Journal of Natural Products
Article
1
1143, 1061 cm−1; H and 13C NMR spectroscopic data (see Tables 1
and then activated with 1 μg/mL of LPS for 20 h. Indomethacin (IC50
= 28.56 μM) was used as a positive control. The culture supernatant
(50 μL) of each well was collected, and the concentration of NO was
further measured by using Griess reagent. The absorbance was
measured at 540 nm with a microplate reader. The nitrite level in the
samples was calculated from the standard curve created from known
concentrations of sodium nitrite.
and 3); HRESIMS m/z 667.2996 [M + Na]+ (calcd for C35H48O11Na,
667.3089).
Xylorumphiin F (2): white, amorphous powder; [α]20 +18 (c 0.1,
D
MeOH); UV (MeOH) λmax (log ε) 208 (3.50) nm; IR (neat) νmax
3424 (br), 2970, 2928, 2863, 1726, 1461, 1383, 1302, 1189, 1140,
1059 cm−1; 1H and 13C NMR spectroscopic data (see Tables 1 and 3);
HRESIMS m/z 657.3270 [M − H]− (calcd for C36H49O11, 657.3269).
2-Hydroxyxylorumphiin F (3): white, amorphous powder; [α]20
ASSOCIATED CONTENT
* Supporting Information
D
■
−19 (c 0.1, MeOH); UV (MeOH) λmax (log ε) 209 (3.61) nm; IR
S
(neat) νmax 3404, 2970, 2934, 2876, 1720, 1454, 1379, 1392, 1227,
1D and 2D NMR spectra of compounds 1−7 and CIF file for
compound 4. These materials are available free of charge via the
1
1143, 1062 cm−1; H and 13C NMR spectroscopic data (see Tables 1
and 3); HRESIMS m/z 697.3169 [M + Na]+ (calcd for C36H50O12Na,
697.3194).
Xylorumphiin G (4): colorless crystals (MeOH); mp 162−164 °C;
[α]20D −68 (c 0.1, MeOH); UV (MeOH) λmax (log ε) 208 (3.51) nm;
IR (neat) νmax 3410 (br), 2967, 2924, 2883, 1720, 1457, 1377, 1292,
AUTHOR INFORMATION
Corresponding Author
Notes
■
1
1189, 1147, 1066 cm−1; H and 13C NMR spectroscopic data (see
Tables 1 and 3); HRESIMS m/z 687.3390 [M − H]− (calcd for
C37H51O12, 687.3381).
Xylorumphiin H (5): white, amorphous powder; [α]20 +12 (c 0.1,
The authors declare no competing financial interest.
D
MeOH); UV (MeOH) λmax (log ε) 210 (3.64) nm; IR (neat) νmax
3440 (br), 2967, 2931, 2883, 1717, 1461, 1370, 1260, 1224, 1137,
1014 cm−1; 1H and 13C NMR spectroscopic data (see Tables 2 and 3);
HRESIMS m/z 631.2781 [M − H]− (calcd for C33H43O12, 631.2749).
ACKNOWLEDGMENTS
■
The authors are grateful for the financial support from Thailand
Research Fund and Chulalongkorn University through the
Royal Golden Jubilee Ph.D. Program (PHD/0009/2553) and
the 90th Anniversary of Chulalongkorn University Fund
(Ratchadaphiseksomphot Endownment Fund). This research
has also been partially supported by the Ratchadaphiseksom-
phot Endowment Fund of Chulalongkorn University
(RES560530208-AS).
Xylorumphiin I (6): white, amorphous powder; [α]20 +4 (c 0.1,
D
MeOH); UV (MeOH) λmax (log ε) 209 (4.16) nm; IR (neat) νmax
3375 (br), 2973, 2934, 2876, 1720, 1461, 1377, 1289, 1260, 1143,
1062 cm−1; 1H and 13C NMR spectroscopic data (see Tables 2 and 3);
HRESIMS m/z 685.3266 [M − H]− (calcd for C37H49O12, 685.3319).
Xylorumphiin J (7): white solid; decomposed at 238 °C; [α]20D −7
(c 0.1, MeOH); UV (MeOH) λmax (log ε) 210 (3.64) nm; IR (neat)
νmax 3492, 2957, 2924, 2850, 1730, 1460, 1428, 1370, 1311, 1240,
1088 cm−1; 1H and 13C NMR spectroscopic data (see Tables 2 and 3);
HRESIMS m/z 701.2471 [M − H]− (calcd for C35H41O15, 701.2440).
X-ray Crystallographic Analysis of 4. The single-crystal X-ray
diffraction data were collected at 296 K on a Bruker APEX-II CCD
diffractometer with Mo Kα radiation (λ = 0.710 73 Å). The crystal
structure was solved by direct methods using SHELXS-9718 and
refined with full-matrix least-squares on all F2 data using SHELXS-97
to final R values.19 All non-hydrogen atoms were anisotropically
refined, except for the oxygen C-3A atom, which was refined
isotropically. The C-3A atom is disordered over two positions with
site occupancies of 0.52 and 0.48. All hydrogen atoms were added at
calculated positions and refined using a rigid model, with C−H = 0.93
Å (aromatic), 0.97 Å (CH2), and 0.98 Å (CH3) and O−H = 0.82 Å.
Crystallographic data for 4 have been deposited with the Cambridge
Crystallographic Data Centre under the deposition number CCDC
998571.
REFERENCES
■
(1) Koul, O.; Sing, G.; Singh, R.; Daniewski, W. M.; Berlozecki, S. J.
Biosci. (Bangalore, India) 2004, 29, 409−416.
(2) Endo, T. M.; Shimada, T.; Moriguchi, T.; Hidaki, T.; Matsumoto,
R.; Hasegawa, S.; Omura, M. Plant Biotechnol. 2002, 19, 397−403.
(3) Nakagawa, H.; Duan, H.; Takaishi, Y. Chem. Pharm. Bull. 2001,
49, 649−651.
(4) Zhou, Y.; Cheng, F.; Wu, J.; Zou, K. J. Nat. Prod. 2006, 69, 1083−
1085.
(5) Cui, J.; Wu, J.; Deng, Z.; Proksch, P.; Lin, W. J. Nat. Prod. 2007,
70, 772−778.
(6) Yin, S.; Wang, X.-N.; Fan, C.-Q.; Lin, L.-P.; Ding, J.; Yue, J.-M. J.
Nat. Prod. 2007, 70, 682−685.
(7) Li, M.-N.; Yang, X.-B.; Pan, J.-U.; Feng, G.; Xiao, Q.; Sinkkonen,
J.; Satyanandamurty, T.; Wu, J. J. Nat. Prod. 2009, 72, 2110−2114.
(8) Li, M.-N.; Yang, S.-X.; Pan, J.-U.; Xiao, Q.; Satyanandamurty, T.;
Wu, J. J. Nat. Prod. 2009, 72, 1657−1662.
(9) Pudhom, K.; Sommit, D.; Nuclear, P.; Ngamrojanavanich, N.;
Petsom, A. J. Nat. Prod. 2009, 72, 2188−2191.
(10) Pudhom, K.; Sommit, D.; Nuclear, P.; Ngamrojanavanich, N.;
Petsom, A. J. Nat. Prod. 2010, 73, 263−266.
Crystal data of 4: colorless crystal; C37H50O12, Mr = 688.80, prism,
a = 12.1699(10) Å, b = 12.3165(16) Å, c = 24.075(3) Å, space group
P212121, Z = 4, V = 3608.6(7) Å3, μ(Mo Kα) = 0.07 mm−1, and
F(000) = 1200. Crystal dimensions: 0.38 × 0.22 × 0.20 mm3.
Independent reflections: 3394 (Rint = 0.035).
Absolute Configuration of C-2 of the 2-Methylbutyryl
Group of Xylorumphiins F, G, and I (2, 4, and 6) and 2-
Hydroxyxylorumphiin F (3). Each compound (3 mg) was dissolved
in EtOH (0.5 mL) and treated with 10% aqueous KOH solution (1
mL). After stirring overnight, the mixture was concentrated and
washed with EtOAc (×3), and the aqueous layer was acidified with
HCl to pH 3.0 and extracted with CH2Cl2 (×3). The combined
organic layer was subjected to Sephadex LH-20 CC (CH2Cl2−MeOH,
(11) Sarigaputi, C.; Nuanyai, T.; Teerawatananond, T.; Pengpreecha,
S.; Muangsin, N.; Pudhom, K. J. Nat. Prod. 2010, 73, 1456−1459.
(12) Ravangpai, W.; Sommit, D.; Teerawatananond, T.; Sinpranee,
N.; Palaga, T.; Pengpreecha, S.; Muangsin, N.; Pudhom, K. Bioorg.
Med. Lett. 2011, 21, 4485−4489.
(13) Sarigaputi, C.; Teerawatananond, T.; Pengpreecha, S.;
Muangsin, N.; Pudhom, K. Acta Crystallogr. 2010, E66, o1348−o1349.
(14) Kokpol, U.; Chavasiri, W.; Tip-Pyang, S.; Veerachato, G.; Zhao,
F.; Simpson, J.; Weavers, R. T. Phytochemistry 1996, 41, 903−905.
(15) Meyers, A. I.; Knaus, G.; Kamata, K. J. Am. Chem. Soc. 1974, 96,
268−270.
1:1) to yield 2S-methylbutanoic acid, [α]20 +10, +12, +15, and +18,
D
for compounds 2−4 and 6, respectively, lit. [α]25 +19.2.16
D
Anti-inflammatory Bioassay. The inhibitory effects of samples
on NO production were evaluated in LPS-activated murine macro-
phage J774.A1 cells according to a reported method.20 The cell lines
were seeded in 24-well plates with 1 × 105 cells/well and allowed to
adhere for 24 h at 37 °C in 5% CO2. The cells were pretreated with
various concentrations of test compounds or vehicle (DMSO) for 2 h
(16) Brechbuhler, S.; Buchi, G.; Milne, G. J. Org. Chem. 1967, 32,
̈
̈
2641−2642.
(17) Roy, A. D.; Kumar, R.; Gupta, P.; Khaliq, T.; Narender, T.;
Aggarwal, V.; Roy, R. Magn. Reson. Chem. 2006, 11, 1054−1057.
F
dx.doi.org/10.1021/np5003687 | J. Nat. Prod. XXXX, XXX, XXX−XXX